{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:58:43Z","timestamp":1790294323691,"version":"4.1.0"},"reference-count":26,"publisher":"Georg Thieme Verlag KG","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Semin Liver Dis"],"abstract":"<jats:p>The purpose of these expert practical recommendations is to provide an updated, clinically oriented overview of the screening, diagnosis, treatment, and surveillance of portal hypertension (PH) in cirrhosis. Building on recent advances in the understanding and management of PH, this review summarizes evidence-based strategies for the identification and management of clinically significant PH in patients with advanced chronic liver disease, in-line with the recent Baveno VIII consensus recommendations. It presents practical clinical pathways for risk stratification, the prevention of first and further decompensation, and the longitudinal follow-up focusing on promising non-invasive techniques, also in terms of diagnosing resolution of clinically significant PH. In addition, the review offers a comprehensive overview of the contemporary management of acute variceal bleeding, including initial resuscitation, pharmacological and endoscopic therapy, and the appropriate use of transjugular intrahepatic portosystemic shunts and other invasive strategies. In conclusion, these expert recommendations offer an updated and practical decision tool for the management of PH in cirrhosis by combining the latest evidence with expert consensus to optimize patient care and improve clinical outcomes.<\/jats:p>","DOI":"10.1055\/a-2956-4625","type":"journal-article","created":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:29:31Z","timestamp":1789082971000},"source":"Crossref","is-referenced-by-count":0,"title":["Expert Practical Recommendations for Portal Hypertension in Cirrhosis"],"prefix":"10.1055","author":[{"given":"Daniel","family":"Segna","sequence":"additional","affiliation":[{"name":"Liver Intensive Care Unit, Liver Unit, Hospital Clinic, Spain","place":["Barcelona"]},{"name":"Inselspital Bern and University of Bern, Switzerland","place":["Bern"],"department":["Department of Visceral Surgery, Medicine and Hepatology"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asunci\u00f3n","family":"Ojeda","sequence":"additional","affiliation":[{"name":"Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Cl\u00ednic, FRCB-IDIBAPS (Fundaci\u00f3 de Recerca Cl\u00ednic Barcelona-Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer), Barcelona, Spain. CIBEREHD (Centro de Investigaci\u00f3n Biom\u00e9dica en Red. Enfermedades Hep\u00e1ticas y Digestivas). Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE-Liver). CSUR Centro de referencia del Sistema Nacional de Salud en Enfermedad Hep\u00e1tica Compleja. Departament de Medicina i Ci\u00e8ncies de la Salut. Universitat de Barcelona. AGAUR SGR2021, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Torres","sequence":"additional","affiliation":[{"name":"Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Cl\u00ednic, FRCB-IDIBAPS (Fundaci\u00f3 de Recerca Cl\u00ednic Barcelona-Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer), Barcelona, Spain. CIBEREHD (Centro de Investigaci\u00f3n Biom\u00e9dica en Red. Enfermedades Hep\u00e1ticas y Digestivas). Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE-Liver). CSUR Centro de referencia del Sistema Nacional de Salud en Enfermedad Hep\u00e1tica Compleja. Departament de Medicina i Ci\u00e8ncies de la Salut. Universitat de Barcelona. AGAUR SGR2021, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9032-4954","authenticated-orcid":false,"given":"Juan Carlos","family":"Garc\u00eda-Pag\u00e1n","sequence":"additional","affiliation":[{"name":"Barcelona Hepatic Hemodynamic Laboratory, Liver Unit, Hospital Cl\u00ednic, FRCB-IDIBAPS (Fundaci\u00f3 de Recerca Cl\u00ednic Barcelona-Institut d'Investigacions Biom\u00e8diques August Pi i Sunyer), Barcelona, Spain. CIBEREHD (Centro de Investigaci\u00f3n Biom\u00e9dica en Red. Enfermedades Hep\u00e1ticas y Digestivas). Health Care Provider of the European Reference Network on Rare Liver Disorders (ERN RARE-Liver). CSUR Centro de referencia del Sistema Nacional de Salud en Enfermedad Hep\u00e1tica Compleja. Departament de Medicina i Ci\u00e8ncies de la Salut. Universitat de Barcelona. AGAUR SGR2021, Catalonia, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"194","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2026.07.030","article-title":"Baveno VIII - Advancing Consensus in Portal Hypertension","author":"Baveno VIII Faculty","year":"2026","journal-title":"J Hepatol"},{"issue":"01","key":"ref2","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S1665-2681(19)31950-7","article-title":"Current concepts on the pathophysiology of portal hypertension","volume":"6","author":"A Rodr\u00edguez-Vilarrupla","year":"2007","journal-title":"Ann Hepatol"},{"issue":"04","key":"ref3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/s41575-018-0097-3","article-title":"Hepatic microcirculation and mechanisms of portal hypertension","volume":"16","author":"J Gracia-Sancho","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"04","key":"ref4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - Renewing consensus in portal hypertension","volume":"76","author":"R de Franchis","year":"2022","journal-title":"J Hepatol"},{"issue":"04","key":"ref5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jhep.2022.05.033","article-title":"Porto-sinusoidal vascular disorder","volume":"77","author":"A De Gottardi","year":"2022","journal-title":"J Hepatol"},{"issue":"05","key":"ref6","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis","volume":"79","author":"D E Kaplan","year":"2024","journal-title":"Hepatology"},{"issue":"02","key":"ref7","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"C Ripoll","year":"2007","journal-title":"Gastroenterology"},{"issue":"08","key":"ref8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJMra2215289","article-title":"Acute kidney injury in patients with cirrhosis","volume":"388","author":"M K Nadim","year":"2023","journal-title":"N Engl J Med"},{"issue":"03","key":"ref9","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis - 2021 update","volume":"75","author":"A Berzigotti","year":"2021","journal-title":"J Hepatol"},{"issue":"09","key":"ref10","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2468-1253(23)00150-4","article-title":"Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis","volume":"8","author":"E Dajti","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"12","key":"ref11","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/S2468-1253(24)00234-6","article-title":"Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study","volume":"9","author":"M Jachs","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"02","key":"ref12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jhep.2025.08.001","article-title":"EASL Clinical Practice Guidelines on vascular diseases of the liver","volume":"84","author":"European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu","year":"2026","journal-title":"J Hepatol"},{"issue":"01","key":"ref13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.jhep.2025.01.029","article-title":"EASL Clinical Practice Guidelines on TIPS","volume":"83","author":"European Association for the Study of the Liver","year":"2025","journal-title":"J Hepatol"},{"issue":"01","key":"ref14","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/HEP.0000000000000530","article-title":"AASLD Practice Guidance on the use of TIPS, variceal embolization, and retrograde transvenous obliteration in the management of variceal hemorrhage","volume":"79","author":"E W Lee","year":"2024","journal-title":"Hepatology"},{"issue":"12","key":"ref15","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1097\/LVT.0000000000000531","article-title":"Management of portal vein thrombosis in candidates for liver transplant","volume":"31","author":"F Turon","year":"2025","journal-title":"Liver Transpl"},{"issue":"06","key":"ref16","first-page":"548","article-title":"Ultrasound in portal hypertension--part 1","volume":"32","author":"A Berzigotti","year":"2011","journal-title":"Ultraschall Med"},{"issue":"01","key":"ref17","first-page":"8","article-title":"Ultrasound in portal hypertension--part 2--and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension","volume":"33","author":"A Berzigotti","year":"2012","journal-title":"Ultraschall Med"},{"issue":"06","key":"ref18","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1002\/hep.28824","article-title":"Noninvasive tools and risk of clinically significant portal hypertension and varices in compensated cirrhosis: The \u201cAnticipate\u201d study","volume":"64","author":"J G Abraldes","year":"2016","journal-title":"Hepatology"},{"issue":"02","key":"ref19","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/j.gastro.2025.08.020","article-title":"The ANTICIPATE-NASH models stratify better the risk of clinical events than histology in metabolic dysfunction-associated steatotic liver disease patients with advanced chronic liver disease","volume":"170","author":"L Aceituno","year":"2026","journal-title":"Gastroenterology"},{"issue":"04","key":"ref20","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jhep.2025.10.019","article-title":"Predicting hepatic decompensation using non-invasive tests in a contemporary multicentre cohort of patients with cACLD","volume":"84","author":"M Jachs","year":"2026","journal-title":"J Hepatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"\u03b2 blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"C Villanueva","year":"2019","journal-title":"Lancet"},{"issue":"02","key":"ref22","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/hep.31884","article-title":"Diagnosis, evaluation, and management of ascites, spontaneous bacterial peritonitis and hepatorenal syndrome: 2021 Practice Guidance by the American Association for the Study of Liver Diseases","volume":"74","author":"S W Biggins","year":"2021","journal-title":"Hepatology"},{"issue":"03","key":"ref23","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.jhep.2022.06.001","article-title":"EASL Clinical Practice Guidelines on the management of hepatic encephalopathy","volume":"77","author":"European Association for the Study of the Liver","year":"2022","journal-title":"J Hepatol"},{"issue":"02","key":"ref24","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","author":"European Association for the Study of the Liver","year":"2018","journal-title":"J Hepatol"},{"issue":"06","key":"ref25","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/HEP.0000000000001644","article-title":"AASLD AST Practice Guideline on adult liver transplantation: Candidate evaluation","volume":"83","author":"L Dove","year":"2026","journal-title":"Hepatology"},{"issue":"06","key":"ref26","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1016\/j.jhep.2024.07.032","article-title":"EASL Clinical Practice Guidelines on liver transplantation","volume":"81","author":"European Association for the Study of the Liver","year":"2024","journal-title":"J Hepatol"}],"container-title":["Seminars in Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/a-2956-4625.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:05:15Z","timestamp":1790291115000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/a-2956-4625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,10]]},"references-count":26,"URL":"https:\/\/doi.org\/10.1055\/a-2956-4625","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["0272-8087","1098-8971"],"issn-type":[{"value":"0272-8087","type":"print"},{"value":"1098-8971","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,10]]},"published":{"date-parts":[[2026,9,10]]}}}